Clinical Trial Update: [18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update for [18F]AlF-NOTA-octreotide PET/MRI in stroke and carotid artery disease; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Carotid Artery Disease
• Carotid Artery Stenosis
• Stroke
• Transient Ischemic Attack

Drugs mentioned

• [18F]AlF-NOTA-octreotide (18F-AlF-NOTA-octreotide)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Stroke (CVA) or TIA, Carotid Artery Plaque | Phase 2 | Status: RECRUITING